Moderna and Pfizer have previously announced that the updated vaccines would be ready this fall. The FDA’s approval comes amid a steady rise in reported COVID-19 cases and hospitalizations in ...
Moderna beat first-quarter expectations Thursday. The news could bolster Moderna stock which is approaching its first ...
An updated COVID booster shot can be expected this fall ... XBB.1.5 Omicron strain and is expected to be effective against ...
All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.
Booster shots help to "remind" it of how to respond to a virus ... for certain higher-risk individuals were also recommended. In September 2023, the FDA authorized Pfizer-BioNTech's updated vaccine ...
ORLANDO, Fla. (FNN) – Community advocate Cynthia Harris filed as a NPA candidate to run for the open Orange County Supervisor ...
The Delaware State Police continues to investigate the fatal pedestrian hit-and-run crash that occurred on Harbeson Road last ...
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...
Pfizer (NYSE: PFE) on Friday announced the FDA's approval of its one-time gene therapy, called Beqvez, for the rare genetic bleeding disorder hemophilia B. It marks the large pharmaceutical ...
Ten years after dipping its toes into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained FDA approval for the acquired treatment. The U.S. regulator has endorsed ...
Pfizer also seeks FDA approval for its experimental antibody, marstacimab, to treat hemophilia A and B. The company is also developing a gene therapy for Duchenne muscular dystrophy, a genetic ...